{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:33:28Z","timestamp":1792172008083,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,19]],"date-time":"2018-08-19T00:00:00Z","timestamp":1534636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,19]],"date-time":"2018-08-19T00:00:00Z","timestamp":1534636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21NS099844"],"award-info":[{"award-number":["1R21NS099844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21NS099844"],"award-info":[{"award-number":["1R21NS099844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015330","name":"Max Kade Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["401837860"],"award-info":[{"award-number":["401837860"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013149","name":"Meningioma Mommas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013149","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012131","name":"Brain Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001453","name":"American Brain Tumor Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00401-018-1899-7","type":"journal-article","created":{"date-parts":[[2018,8,19]],"date-time":"2018-08-19T09:14:46Z","timestamp":1534670086000},"page":"779-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["DMD genomic deletions characterize a subset of progressive\/higher-grade meningiomas with poor outcome"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-6719","authenticated-orcid":false,"given":"Tareq A.","family":"Juratli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naema","family":"Nayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa S.","family":"Tummala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria L.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martinez-Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Selig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanna V.","family":"Bihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh M.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lastrapes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Daubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Meinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia S.","family":"Bertalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Batten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo B.","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat O.","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel N.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Fred G.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Schackert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,19]]},"reference":[{"key":"1899_CR1","doi-asserted-by":"publisher","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-17-1856","volume":"23","author":"E Arbajian","year":"2017","unstructured":"Arbajian E, Puls F, Antonescu CR, Amary F, Sciot R, Debiec-Rychter M et al (2017) In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets. Clin Cancer Res 23:7426\u20137434. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1856","journal-title":"Clin Cancer Res"},{"issue":"13 Supplement","key":"1899_CR2","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1158\/1538-7445.AM2017-3580","volume":"77","author":"Mehrtash DIB Babadi","year":"2017","unstructured":"Babadi Mehrtash DIB, Lee Samuel K, Andrey Smirnov AC, Lichtenstein Lee et al (2017) Abstract 3580: gATK CNV: copy-number variation discovery from coverage data. Am Assoc Cancer Res 77(13 Supplement):3580. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-3580","journal-title":"Am Assoc Cancer Res"},{"key":"1899_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899\u2013905. https:\/\/doi.org\/10.1038\/nature08822","journal-title":"Nature"},{"key":"1899_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0014-7","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK et al (2017) Genomic landscape of high-grade meningiomas. NPJ Genom Med. https:\/\/doi.org\/10.1038\/s41525-017-0014-7","journal-title":"NPJ Genom Med"},{"key":"1899_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","volume":"26","author":"S Blitshteyn","year":"2008","unstructured":"Blitshteyn S, Crook JE, Jaeckle KA (2008) Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 26:279\u2013282. https:\/\/doi.org\/10.1200\/JCO.2007.14.2133","journal-title":"J Clin Oncol"},{"key":"1899_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669. https:\/\/doi.org\/10.1016\/S0002-9440(10)61737-3","journal-title":"Am J Pathol"},{"key":"1899_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289. https:\/\/doi.org\/10.1038\/ng.2526","journal-title":"Nat Genet"},{"key":"1899_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T et al (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30:413\u2013421. https:\/\/doi.org\/10.1038\/nbt.2203","journal-title":"Nat Biotechnol"},{"key":"1899_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1096\/fj.06-7353com","volume":"21","author":"JS Chamberlain","year":"2007","unstructured":"Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21:2195\u20132204. https:\/\/doi.org\/10.1096\/fj.06-7353com","journal-title":"FASEB J"},{"key":"1899_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/CCO.0b013e328356364d","volume":"24","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma. Curr Opin Oncol 24:666\u2013671. https:\/\/doi.org\/10.1097\/CCO.0b013e328356364d","journal-title":"Curr Opin Oncol"},{"key":"1899_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41467-017-01355-0","volume":"8","author":"J Cheng","year":"2017","unstructured":"Cheng J, Demeulemeester J, Wedge DC, Vollan HKM, Pitt JJ, Russnes HG et al (2017) Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nat Commun 8:1221. https:\/\/doi.org\/10.1038\/s41467-017-01355-0","journal-title":"Nat Commun"},{"key":"1899_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31:213\u2013219. https:\/\/doi.org\/10.1038\/nbt.2514","journal-title":"Nat Biotechnol"},{"key":"1899_CR13","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","volume":"27","author":"K Cibulskis","year":"2011","unstructured":"Cibulskis K, McKenna A, Fennell T, Banks E, DePristo M, Getz G (2011) ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27:2601\u20132602. https:\/\/doi.org\/10.1093\/bioinformatics\/btr446","journal-title":"Bioinformatics"},{"key":"1899_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"1899_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"1899_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","volume":"1772","author":"JM Ervasti","year":"2007","unstructured":"Ervasti JM (2007) Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772:108\u2013117. https:\/\/doi.org\/10.1016\/j.bbadis.2006.05.010","journal-title":"Biochim Biophys Acta"},{"key":"1899_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/gb-2011-12-1-r1","volume":"12","author":"S Fisher","year":"2011","unstructured":"Fisher S, Barry A, Abreu J, Minie B, Nolan J, Delorey TM et al (2011) A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol 12:R1. https:\/\/doi.org\/10.1186\/gb-2011-12-1-r1","journal-title":"Genome Biol"},{"key":"1899_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/humu.21114","volume":"30","author":"KM Flanigan","year":"2009","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT et al (2009) Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat 30:1657\u20131666. https:\/\/doi.org\/10.1002\/humu.21114","journal-title":"Hum Mutat"},{"key":"1899_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nbt.1523","volume":"27","author":"A Gnirke","year":"2009","unstructured":"Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W et al (2009) Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 27:182\u2013189. https:\/\/doi.org\/10.1038\/nbt.1523","journal-title":"Nat Biotechnol"},{"key":"1899_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184\u2013189. https:\/\/doi.org\/10.1111\/bpa.12110","journal-title":"Brain Pathol"},{"key":"1899_CR21","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","volume":"16","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ et al (2010) Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res 16:4155\u20134164. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0891","journal-title":"Clin Cancer Res"},{"key":"1899_CR22","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanc\u0131","year":"2017","unstructured":"Harmanc\u0131 AS, Youngblood MW, Clark VE, Co\u015fkun S, Henegariu O, Duran D et al (2017) Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8:14433. https:\/\/doi.org\/10.1038\/ncomms14433","journal-title":"Nat Commun"},{"key":"1899_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","volume":"10","author":"MF James","year":"2012","unstructured":"James MF, Stivison E, Beauchamp R, Han S, Li H, Wallace MR et al (2012) Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. Mol Cancer Res 10:649\u2013659. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0425-T","journal-title":"Mol Cancer Res"},{"key":"1899_CR24","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.18632\/oncotarget.22650","volume":"8","author":"TA Juratli","year":"2017","unstructured":"Juratli TA, Thiede C, Koerner MVA, Tummala SS, Daubner D, Shankar GM et al (2017) Intratumoral heterogeneity and TERT promoter mutations in progressive\/higher-grade meningiomas. Oncotarget 8:109228\u2013109237. https:\/\/doi.org\/10.18632\/oncotarget.22650","journal-title":"Oncotarget"},{"key":"1899_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","volume":"25","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1986","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233\u2013242","journal-title":"Surg Neurol"},{"key":"1899_CR26","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/cncr.25591","volume":"117","author":"AJ Kane","year":"2011","unstructured":"Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW et al (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272\u20131278. https:\/\/doi.org\/10.1002\/cncr.25591","journal-title":"Cancer"},{"key":"1899_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955\u2013963. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol"},{"key":"1899_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00401-013-1195-5","volume":"126","author":"C Koelsche","year":"2013","unstructured":"Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT et al (2013) Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 126:907\u2013915. https:\/\/doi.org\/10.1007\/s00401-013-1195-5","journal-title":"Acta Neuropathol"},{"key":"1899_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1227\/01.neu.0000290895.92695.22","volume":"61","author":"N Krayenb\u00fchl","year":"2007","unstructured":"Krayenb\u00fchl N, Pravdenkova S, Al-Mefty O (2007) De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery 61:495\u2013503. https:\/\/doi.org\/10.1227\/01.neu.0000290895.92695.22 (discussion 503\u2013494)","journal-title":"Neurosurgery"},{"key":"1899_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/322073a0","volume":"322","author":"LM Kunkel","year":"1986","unstructured":"Kunkel LM, Hejtmancik JF, Caskey CT, Speer A, Monaco AP, Middlesworth W et al (1986) Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322:73\u201377. https:\/\/doi.org\/10.1038\/322073a0","journal-title":"Nature"},{"key":"1899_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4161\/cc.6.2.3733","volume":"6","author":"H K\u00f6rner","year":"2007","unstructured":"K\u00f6rner H, Epanchintsev A, Berking C, Schuler-Thurner B, Speicher MR, Menssen A et al (2007) Digital karyotyping reveals frequent inactivation of the dystrophin\/DMD gene in malignant melanoma. Cell Cycle 6:189\u2013198. https:\/\/doi.org\/10.4161\/cc.6.2.3733","journal-title":"Cell Cycle"},{"key":"1899_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.ejhg.5201465","volume":"13","author":"T Lalic","year":"2005","unstructured":"Lalic T, Vossen RH, Coffa J, Schouten JP, Guc-Scekic M, Radivojevic D et al (2005) Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 13:1231\u20131234. https:\/\/doi.org\/10.1038\/sj.ejhg.5201465","journal-title":"Eur J Hum Genet"},{"key":"1899_CR33","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","volume":"17","author":"D Lallemand","year":"2003","unstructured":"Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17:1090\u20131100. https:\/\/doi.org\/10.1101\/gad.1054603","journal-title":"Genes Dev"},{"key":"1899_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656","journal-title":"Bioinformatics"},{"key":"1899_CR35","unstructured":"Louis DN OH, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A et al (2016) WHO classification of tumours of the central nervous system, vol 1. Revised 4th Edition"},{"key":"1899_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.18632\/oncotarget.10426","volume":"8","author":"LN Luce","year":"2017","unstructured":"Luce LN, Abbate M, Cotignola J, Giliberto F (2017) Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations. Oncotarget 8:145\u2013155. https:\/\/doi.org\/10.18632\/oncotarget.10426","journal-title":"Oncotarget"},{"key":"1899_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000112061","volume":"119","author":"S McAvoy","year":"2007","unstructured":"McAvoy S, Ganapathiraju S, Perez DS, James CD, Smith DI (2007) DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors. Cytogenet Genome Res 119:196\u2013203. https:\/\/doi.org\/10.1159\/000112061","journal-title":"Cytogenet Genome Res"},{"key":"1899_CR38","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046\u20132056","journal-title":"Cancer"},{"key":"1899_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox231","author":"M Peyre","year":"2017","unstructured":"Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T et al (2017) De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nox231","journal-title":"Neuro Oncol"},{"key":"1899_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1083\/jcb.200905048","volume":"186","author":"KW Prins","year":"2009","unstructured":"Prins KW, Humston JL, Mehta A, Tate V, Ralston E, Ervasti JM (2009) Dystrophin is a microtubule-associated protein. J Cell Biol 186:363\u2013369. https:\/\/doi.org\/10.1083\/jcb.200905048","journal-title":"J Cell Biol"},{"key":"1899_CR41","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1002\/humu.22771","volume":"36","author":"AH Ramos","year":"2015","unstructured":"Ramos AH, Lichtenstein L, Gupta M, Lawrence MS, Pugh TJ, Saksena G et al (2015) Oncotator: cancer variant annotation tool. Hum Mutat 36:E2423\u2013E2429. https:\/\/doi.org\/10.1002\/humu.22771","journal-title":"Hum Mutat"},{"key":"1899_CR42","first-page":"2386","volume":"53","author":"SA Rempel","year":"1993","unstructured":"Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML (1993) Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53:2386\u20132392","journal-title":"Cancer Res"},{"key":"1899_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Piro RM, Jones DT, Simon M, Ketter R, Kool M et al (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125:351\u2013358. https:\/\/doi.org\/10.1007\/s00401-013-1093-x","journal-title":"Acta Neuropathol"},{"key":"1899_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","volume":"488","author":"G Robinson","year":"2012","unstructured":"Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43\u201348. https:\/\/doi.org\/10.1038\/nature11213","journal-title":"Nature"},{"key":"1899_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv377","journal-title":"J Natl Cancer Inst"},{"key":"1899_CR46","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"1899_CR47","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK (2012) Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28:1811\u20131817. https:\/\/doi.org\/10.1093\/bioinformatics\/bts271","journal-title":"Bioinformatics"},{"key":"1899_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/now235","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol 19:535\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/now235","journal-title":"Neuro Oncol"},{"key":"1899_CR49","first-page":"287","volume":"9","author":"RJ Shaw","year":"1998","unstructured":"Shaw RJ, McClatchey AI, Jacks T (1998) Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin. Cell Growth Differ 9:287\u2013296","journal-title":"Cell Growth Differ"},{"key":"1899_CR50","doi-asserted-by":"publisher","first-page":"7757","DOI":"10.1074\/jbc.273.13.7757","volume":"273","author":"RJ Shaw","year":"1998","unstructured":"Shaw RJ, McClatchey AI, Jacks T (1998) Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. J Biol Chem 273:7757\u20137764","journal-title":"J Biol Chem"},{"key":"1899_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1535-7163.MCT-17-0419","volume":"17","author":"KM Smith","year":"2018","unstructured":"Smith KM, Fagan PC, Pomari E, Germano G, Frasson C, Walsh C et al (2018) Antitumor activity of entrectinib, a Pan-TRK, ROS1, and ALK inhibitor, in. Mol Cancer Ther 17:455\u2013463. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0419","journal-title":"Mol Cancer Ther"},{"key":"1899_CR52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1203619","volume":"333","author":"DA Solomon","year":"2011","unstructured":"Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT et al (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333:1039\u20131043. https:\/\/doi.org\/10.1126\/science.1203619","journal-title":"Science"},{"key":"1899_CR53","doi-asserted-by":"publisher","DOI":"10.3171\/2016.8.jns161076","author":"MR Strickland","year":"2016","unstructured":"Strickland MR, Gill CM, Nayyar N, D\u2019Andrea MR, Thiede C, Juratli TA et al (2016) Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. J Neurosurg. https:\/\/doi.org\/10.3171\/2016.8.jns161076","journal-title":"J Neurosurg"},{"key":"1899_CR54","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P (2015) Sambamba: fast processing of NGS alignment formats. Bioinformatics 31:2032\u20132034. https:\/\/doi.org\/10.1093\/bioinformatics\/btv098","journal-title":"Bioinformatics"},{"key":"1899_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2990.2012.01250.x","volume":"38","author":"LE Taylor","year":"2012","unstructured":"Taylor LE, Kaminoh YJ, Rodesch CK, Flanigan KM (2012) Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens. Neuropathol Appl Neurobiol 38:591\u2013601. https:\/\/doi.org\/10.1111\/j.1365-2990.2012.01250.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1899_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","volume":"125","author":"J Van der Meulen","year":"2015","unstructured":"Van der Meulen J, Sanghvi V, Mavrakis K, Durinck K, Fang F, Matthijssens F et al (2015) The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood 125:13\u201321. https:\/\/doi.org\/10.1182\/blood-2014-05-577270","journal-title":"Blood"},{"key":"1899_CR57","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1080\/15384101.2015.1064676","volume":"14","author":"Y Wang","year":"2015","unstructured":"Wang Y, Fletcher JA (2015) Cell cycle and dystrophin dysregulation in GIST. Cell Cycle 14:2713\u20132714. https:\/\/doi.org\/10.1080\/15384101.2015.1064676","journal-title":"Cell Cycle"},{"key":"1899_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ng.2974","volume":"46","author":"Y Wang","year":"2014","unstructured":"Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G et al (2014) Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat Genet 46:601\u2013606. https:\/\/doi.org\/10.1038\/ng.2974","journal-title":"Nat Genet"},{"key":"1899_CR59","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","volume":"94","author":"RG Weber","year":"1997","unstructured":"Weber RG, Bostr\u00f6m J, Wolter M, Baudis M, Collins VP, Reifenberger G et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719\u201314724","journal-title":"Proc Natl Acad Sci USA"},{"key":"1899_CR60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000095920","volume":"115","author":"SJ White","year":"2006","unstructured":"White SJ, den Dunnen JT (2006) Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 115:240\u2013246. https:\/\/doi.org\/10.1159\/000095920","journal-title":"Cytogenet Genome Res"},{"key":"1899_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/aje\/kwj254","volume":"164","author":"A Wigertz","year":"2006","unstructured":"Wigertz A, L\u00f6nn S, Mathiesen T, Ahlbom A, Hall P, Feychting M et al (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629\u2013636. https:\/\/doi.org\/10.1093\/aje\/kwj254","journal-title":"Am J Epidemiol"},{"key":"1899_CR62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00273326","volume":"27","author":"H Zankl","year":"1975","unstructured":"Zankl H, Seidel H, Zang KD (1975) Cytological and cytogenetical studies on brain tumors. V. Preferential loss of sex chromosomes in human meningiomas. Humangenetik 27:119\u2013128","journal-title":"Humangenetik"},{"key":"1899_CR63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/biomet\/asq025","volume":"97","author":"NR Zhang","year":"2010","unstructured":"Zhang NR, Siegmund DO, Ji H, Li JZ (2010) Detecting simultaneous changepoints in multiple sequences. Biometrika 97:631\u2013645. https:\/\/doi.org\/10.1093\/biomet\/asq025","journal-title":"Biometrika"},{"key":"1899_CR64","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","volume":"20","author":"Z Zheng","year":"2014","unstructured":"Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD et al (2014) Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 20:1479\u20131484. https:\/\/doi.org\/10.1038\/nm.3729","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-018-1899-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T19:40:37Z","timestamp":1661802037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-018-1899-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,19]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1007\/s00401-018-1899-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,19]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I.M.S. and H.A.E. are employees in Ignyta, and Inc. J.C. is an employee and owns stocks in Ignyta, Inc. All other authors have no conflicts of interest to report with regard to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}